• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在马里兰州巴尔的摩从事街头性工作的跨性别女性中,事件驱动型和长效艾滋病毒暴露前预防制剂的可接受性。

Acceptability of Event-Driven and Long-Acting HIV Pre-Exposure Prophylaxis Formulations Among Transgender Women Engaged in Street-Based Sex Work in Baltimore, Maryland.

作者信息

Rosen Joseph G, Beckham S Wilson, Glick Jennifer L, White Rebecca Hamilton, Park Ju Nyeong, Footer Katherine H A, Sherman Susan G

机构信息

Department of International Health and Behavior, and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Department of Health, Behavior, and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

出版信息

Transgend Health. 2024 Apr 3;9(2):185-191. doi: 10.1089/trgh.2022.0057. eCollection 2024 Apr.

DOI:10.1089/trgh.2022.0057
PMID:38585249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10998007/
Abstract

We assessed acceptability of nonoral HIV pre-exposure prophylaxis (PrEP) formulations among transgender women (TW) engaged in street-based sex work in Baltimore, Maryland. In a -means cluster analysis, TW (=36) were partitioned into groups characterized by high interest in long-acting injectable PrEP only (, 36%), high interest in injectables and subdermal implants (, 36%), and low interest across PrEP formulations (, 28%). TW's interest in novel PrEP agents varied widely across formulations (range: 22-66%) and clustered around numerous relational, occupational, and structural factors, highlighting the importance of availing multiple PrEP formulations for this impacted population.

摘要

我们评估了在马里兰州巴尔的摩从事街头性工作的跨性别女性(TW)对非口服艾滋病毒暴露前预防(PrEP)制剂的接受程度。在一项均值聚类分析中,36名跨性别女性被分为以下几组:仅对长效注射用PrEP高度感兴趣的组(36%)、对注射剂和皮下植入物高度感兴趣的组(36%)以及对所有PrEP制剂兴趣较低的组(28%)。跨性别女性对新型PrEP制剂的兴趣在不同制剂之间差异很大(范围:22%-66%),并且聚集在众多关系、职业和结构因素周围,这凸显了为这一受影响人群提供多种PrEP制剂的重要性。

相似文献

1
Acceptability of Event-Driven and Long-Acting HIV Pre-Exposure Prophylaxis Formulations Among Transgender Women Engaged in Street-Based Sex Work in Baltimore, Maryland.在马里兰州巴尔的摩从事街头性工作的跨性别女性中,事件驱动型和长效艾滋病毒暴露前预防制剂的可接受性。
Transgend Health. 2024 Apr 3;9(2):185-191. doi: 10.1089/trgh.2022.0057. eCollection 2024 Apr.
2
Mapping Interests in Event-Driven and Long-Acting Pre-exposure Prophylaxis Formulations onto the HIV Risk Environment of Street-Based Female Sex Workers: A Latent Class Analysis.将事件驱动型和长效暴露前预防配方制剂的兴趣映射到街头女性性工作者的 HIV 风险环境中:潜在类别分析。
AIDS Behav. 2022 Jun;26(6):1992-2002. doi: 10.1007/s10461-022-03613-9. Epub 2022 Apr 1.
3
PrEP Use Among Black Transgender Women: A Qualitative Study on Barriers to PrEP Use and the Power and Promise of Community.黑人跨性别女性中的暴露前预防用药情况:关于暴露前预防用药障碍以及社区力量与前景的定性研究
Arch Sex Behav. 2025 Apr 22. doi: 10.1007/s10508-025-03130-5.
4
Understanding the social and structural context of oral PrEP delivery: an ethnography exploring barriers and facilitators impacting transgender women who engage in street-based sex work in Baltimore, Maryland.理解口服 PrEP 提供的社会和结构背景:一项探索影响马里兰州巴尔的摩从事街头性工作的跨性别女性的障碍和促进因素的民族志研究。
AIDS Res Ther. 2023 Sep 20;20(1):69. doi: 10.1186/s12981-023-00556-6.
5
Willingness to Use Pre-Exposure Prophylaxis (PrEP) for HIV Prevention and PrEP Implementation Preferences Among Transgender Women in Malaysia.马来西亚跨性别女性中使用暴露前预防(PrEP)预防艾滋病毒的意愿及PrEP实施偏好
Transgend Health. 2020 Dec 11;5(4):258-266. doi: 10.1089/trgh.2020.0003. eCollection 2020 Dec.
6
Perspectives on long-acting formulations of pre-exposure prophylaxis (PrEP) among men who have sex with men who are non-adherent to daily oral PrEP in the United States.美国男男性行为者对每日口服暴露前预防(PrEP)药物不依从者对长效 PrEP 制剂的看法。
BMC Public Health. 2023 Aug 28;23(1):1643. doi: 10.1186/s12889-023-16382-4.
7
Intention to Use Different Formulations of Longer Acting HIV Pre-Exposure Prophylaxis Among Transgender and Gender Expansive Individuals: The Roles of Social Vulnerability and Medical Mistrust.不同长效抗 HIV 暴露前预防制剂使用意向在跨性别和性别多样化个体中的差异:社会脆弱性和医疗不信任的作用。
AIDS Patient Care STDS. 2024 Feb;38(2):51-60. doi: 10.1089/apc.2023.0211.
8
Need for informed providers: exploring LA-PrEP access in focus groups with PrEP-indicated communities in Baltimore, Maryland.知情提供者的需求:在马里兰州巴尔的摩的有接受 PrEP 指征的社区的焦点小组中探索 LA-PrEP 的可及性。
BMC Public Health. 2024 May 8;24(1):1258. doi: 10.1186/s12889-024-18595-7.
9
Long-Acting Injectable Pre-Exposure Prophylaxis Perceptions and Preferences Among Transgender and Nonbinary Young Adults in the United States.美国跨性别和非二元性别的年轻成年人对长效注射暴露前预防的认知与偏好
Qual Health Res. 2025 Jan;35(1):74-87. doi: 10.1177/10497323241265943. Epub 2024 Aug 2.
10
Zero knowledge and high interest in the use of long-acting injectable pre-exposure prophylaxis (PrEP) among adolescent men who have sex with men and transgender women in two capital cities in Brazil.在巴西两个首府城市,男男性行为者和跨性别女性对使用长效注射型暴露前预防(PrEP)的零知识和高度兴趣。
BMC Public Health. 2022 Sep 12;22(1):1728. doi: 10.1186/s12889-022-14134-4.

引用本文的文献

1
Preference for Long-Acting Injectable PrEP Compared With Daily Oral PrEP Among Transgender Women in the U.S.: Findings From a Multisite Cohort.美国跨性别女性中长效注射用暴露前预防药物与每日口服暴露前预防药物的偏好比较:多中心队列研究结果
AJPM Focus. 2025 Jan 8;4(2):100313. doi: 10.1016/j.focus.2025.100313. eCollection 2025 Apr.
2
Long-Acting Injectable Pre-Exposure Prophylaxis Perceptions and Preferences Among Transgender and Nonbinary Young Adults in the United States.美国跨性别和非二元性别的年轻成年人对长效注射暴露前预防的认知与偏好
Qual Health Res. 2025 Jan;35(1):74-87. doi: 10.1177/10497323241265943. Epub 2024 Aug 2.

本文引用的文献

1
Mapping Interests in Event-Driven and Long-Acting Pre-exposure Prophylaxis Formulations onto the HIV Risk Environment of Street-Based Female Sex Workers: A Latent Class Analysis.将事件驱动型和长效暴露前预防配方制剂的兴趣映射到街头女性性工作者的 HIV 风险环境中:潜在类别分析。
AIDS Behav. 2022 Jun;26(6):1992-2002. doi: 10.1007/s10461-022-03613-9. Epub 2022 Apr 1.
2
Transgender Women's Barriers, Facilitators, and Preferences on Tailored Injection Delivery Strategies to Administer Long-Acting Injectable Cabotegravir (CAB-LA) for HIV Pre-exposure Prophylaxis (PrEP).跨性别女性在接受长效注射型卡替拉韦(CAB-LA)用于 HIV 暴露前预防(PrEP)时,对定制注射递药策略的障碍、促进因素和偏好。
AIDS Behav. 2021 Dec;25(12):4180-4192. doi: 10.1007/s10461-021-03357-y. Epub 2021 Jul 3.
3
Medical Gender Affirmation and HIV and Sexually Transmitted Disease Prevention in Transgender Youth: Results from the Survey of Today's Adolescent Relationships and Transitions, 2018.医学性别认同与 HIV 和性传播疾病预防在跨性别青年中的应用:来自今日青少年关系和转型调查(2018 年)的结果。
LGBT Health. 2021 Apr;8(3):181-189. doi: 10.1089/lgbt.2020.0367. Epub 2021 Feb 9.
4
Multilevel Barriers to HIV PrEP Uptake and Adherence Among Black and Hispanic/Latinx Transgender Women in Southern California.南加州黑人和西班牙裔/拉丁裔跨性别女性中 HIV 预防用药的摄取和坚持的多层次障碍。
AIDS Behav. 2021 Jul;25(7):2301-2315. doi: 10.1007/s10461-021-03159-2. Epub 2021 Jan 29.
5
Assessment of Health Conditions and Health Service Use Among Transgender Patients in Canada.加拿大跨性别患者健康状况和卫生服务利用评估。
JAMA Netw Open. 2020 Aug 3;3(8):e2015036. doi: 10.1001/jamanetworkopen.2020.15036.
6
Sex Hormone Therapy and Tenofovir Diphosphate Concentration in Dried Blood Spots: Primary Results of the Interactions Between Antiretrovirals And Transgender Hormones Study.性荷尔蒙疗法与干血斑中替诺福韦二吡呋酯浓度:抗逆转录病毒药物与跨性别激素研究中相互作用的初步结果。
Clin Infect Dis. 2021 Oct 5;73(7):e2117-e2123. doi: 10.1093/cid/ciaa1160.
7
Trends in HIV Preexposure Prophylaxis Prescribing in the United States, 2012-2018.2012-2018 年美国 HIV 暴露前预防用药开具趋势。
JAMA. 2020 Jul 28;324(4):395-397. doi: 10.1001/jama.2020.7312.
8
HIV Testing and PrEP Use in a National Probability Sample of Sexually Active Transgender People in the United States.美国全国性活跃跨性别者概率抽样人群中的 HIV 检测和 PrEP 使用情况。
J Acquir Immune Defic Syndr. 2020 Aug 15;84(5):437-442. doi: 10.1097/QAI.0000000000002403.
9
Transgender Women's Concerns and Preferences on Potential Future Long-Acting Biomedical HIV Prevention Strategies: The Case of Injections and Implanted Medication Delivery Devices (IMDDs).跨性别女性对潜在未来长效生物医学 HIV 预防策略的关注和偏好:以注射和植入式药物输送装置(IMDDs)为例。
AIDS Behav. 2020 May;24(5):1452-1462. doi: 10.1007/s10461-019-02703-5.
10
Long-acting injectable cabotegravir for the prevention of HIV infection.长效注射型卡替拉韦用于预防 HIV 感染。
Curr Opin HIV AIDS. 2020 Jan;15(1):19-26. doi: 10.1097/COH.0000000000000597.